ConductScience.org, home

Trial · NCT03427060

Adverse events30

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherAspartate Aminotransferase IncreasedInvestigationsCoversin Treatment. Ablation Dose: Day 1. 60 mg and 30 mg (12 Hours Apart)010
otherAspartate Aminotransferase IncreasedInvestigationsCoversin Treatment. Initiation Dose: Days 2 - 28. 22.5 mg Twice a Day (12 Hours Apart)112
otherAspartate Aminotransferase IncreasedInvestigationsCoversin Treatment. Maintenance Dose: Days 29 - 180. 45 mg Once Daily010
otherHot FlushVascular disordersCoversin Treatment. Ablation Dose: Day 1. 60 mg and 30 mg (12 Hours Apart)010
otherHot FlushVascular disordersCoversin Treatment. Initiation Dose: Days 2 - 28. 22.5 mg Twice a Day (12 Hours Apart)112
otherHot FlushVascular disordersCoversin Treatment. Maintenance Dose: Days 29 - 180. 45 mg Once Daily010
otherNauseaGastrointestinal disordersCoversin Treatment. Ablation Dose: Day 1. 60 mg and 30 mg (12 Hours Apart)010
otherNauseaGastrointestinal disordersCoversin Treatment. Initiation Dose: Days 2 - 28. 22.5 mg Twice a Day (12 Hours Apart)112
otherNauseaGastrointestinal disordersCoversin Treatment. Maintenance Dose: Days 29 - 180. 45 mg Once Daily010
otherUrinary Tract InfectionInfections and infestationsCoversin Treatment. Ablation Dose: Day 1. 60 mg and 30 mg (12 Hours Apart)010
otherUrinary Tract InfectionInfections and infestationsCoversin Treatment. Initiation Dose: Days 2 - 28. 22.5 mg Twice a Day (12 Hours Apart)112
otherUrinary Tract InfectionInfections and infestationsCoversin Treatment. Maintenance Dose: Days 29 - 180. 45 mg Once Daily010
otherVomitingGastrointestinal disordersCoversin Treatment. Ablation Dose: Day 1. 60 mg and 30 mg (12 Hours Apart)010
otherVomitingGastrointestinal disordersCoversin Treatment. Initiation Dose: Days 2 - 28. 22.5 mg Twice a Day (12 Hours Apart)112
otherVomitingGastrointestinal disordersCoversin Treatment. Maintenance Dose: Days 29 - 180. 45 mg Once Daily010
otherHypoglycaemiaMetabolism and nutrition disordersCoversin Treatment. Ablation Dose: Day 1. 60 mg and 30 mg (12 Hours Apart)010
otherHypoglycaemiaMetabolism and nutrition disordersCoversin Treatment. Initiation Dose: Days 2 - 28. 22.5 mg Twice a Day (12 Hours Apart)114
otherHypoglycaemiaMetabolism and nutrition disordersCoversin Treatment. Maintenance Dose: Days 29 - 180. 45 mg Once Daily010
otherHeadacheNervous system disordersCoversin Treatment. Ablation Dose: Day 1. 60 mg and 30 mg (12 Hours Apart)010
otherHeadacheNervous system disordersCoversin Treatment. Initiation Dose: Days 2 - 28. 22.5 mg Twice a Day (12 Hours Apart)116

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03427060/events